BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 17616479)

  • 1. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
    Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
    J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage.
    Separovic D; Semaan L; Tarca AL; Awad Maitah MY; Hanada K; Bielawski J; Villani M; Luberto C
    Exp Cell Res; 2008 May; 314(8):1860-8. PubMed ID: 18374917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelin synthase activity affects TRIF-dependent signaling of Toll-like receptor 4 in cells stimulated with lipopolysaccharide.
    Prymas K; Świątkowska A; Traczyk G; Ziemlińska E; Dziewulska A; Ciesielska A; Kwiatkowska K
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158549. PubMed ID: 31678513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sphingomyelin synthesis in pulmonary endothelial cell cytoskeletal activation and endotoxin-induced lung injury.
    Anjum F; Joshi K; Grinkina N; Gowda S; Cutaia M; Wadgaonkar R
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):94-103. PubMed ID: 22362386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
    Luberto C; Hannun YA
    J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death.
    Lafont E; Milhas D; Carpentier S; Garcia V; Jin ZX; Umehara H; Okazaki T; Schulze-Osthoff K; Levade T; Benoist H; Ségui B
    Cell Death Differ; 2010 Apr; 17(4):642-54. PubMed ID: 19779494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of sphingomyelin revealed by two toxin-based probes in mammalian cells.
    Yachi R; Uchida Y; Balakrishna BH; Anderluh G; Kobayashi T; Taguchi T; Arai H
    Genes Cells; 2012 Aug; 17(8):720-7. PubMed ID: 22747662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry.
    Chen Y; Yurek DA; Yu L; Wang H; Ehsani ME; Qian YW; Konrad RJ; Jiang XC; Kuo MS; Cao G; Wang J
    Anal Biochem; 2013 Jul; 438(1):61-6. PubMed ID: 23535273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation.
    Kidani Y; Ohshima K; Sakai H; Kohno T; Baba A; Hattori M
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1014-7. PubMed ID: 22209789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
    Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
    J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
    Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
    Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
    J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
    Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
    J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
    Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
    Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The domain responsible for sphingomyelin synthase (SMS) activity.
    Yeang C; Varshney S; Wang R; Zhang Y; Ye D; Jiang XC
    Biochim Biophys Acta; 2008 Oct; 1781(10):610-7. PubMed ID: 18694848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
    Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate.
    Zama K; Mitsutake S; Watanabe K; Okazaki T; Igarashi Y
    Chem Phys Lipids; 2012 Oct; 165(7):760-8. PubMed ID: 23063490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.